vs
Side-by-side financial comparison of First Foundation Inc. (FFWM) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
First Foundation Inc. is the larger business by last-quarter revenue ($48.4M vs $31.1M, roughly 1.6× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -97.9%, a 65.8% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-35.2M). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -2.7%).
John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
FFWM vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $31.1M |
| Net Profit | $-8.0M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | -97.5% | -9.9% |
| Net Margin | -97.9% | -32.1% |
| Revenue YoY | 421.7% | -4.5% |
| Net Profit YoY | 43.0% | -52.0% |
| EPS (diluted) | $-0.09 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | — | ||
| Q3 25 | $63.6M | $31.1M | ||
| Q2 25 | $51.4M | — | ||
| Q1 25 | $71.4M | $35.2M | ||
| Q4 24 | $9.3M | $32.6M | ||
| Q3 24 | $9.2M | $24.7M | ||
| Q2 24 | $57.5M | — | ||
| Q1 24 | $51.1M | $35.7M |
| Q4 25 | $-8.0M | — | ||
| Q3 25 | $-146.3M | $-10.0M | ||
| Q2 25 | $-7.7M | — | ||
| Q1 25 | $6.9M | $-14.8M | ||
| Q4 24 | $-14.1M | $-6.6M | ||
| Q3 24 | $-82.2M | $-16.2M | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $793.0K | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | -97.5% | — | ||
| Q3 25 | -92.7% | -9.9% | ||
| Q2 25 | -21.1% | — | ||
| Q1 25 | 8.8% | -25.7% | ||
| Q4 24 | -247.7% | -6.0% | ||
| Q3 24 | -1276.7% | -46.9% | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | -0.2% | -2.5% |
| Q4 25 | -97.9% | — | ||
| Q3 25 | -230.1% | -32.1% | ||
| Q2 25 | -15.0% | — | ||
| Q1 25 | 9.7% | -42.0% | ||
| Q4 24 | -152.2% | -20.2% | ||
| Q3 24 | -896.9% | -65.7% | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 1.6% | 43.8% |
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-1.78 | $-0.29 | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $0.08 | $-0.47 | ||
| Q4 24 | $-0.24 | $-0.25 | ||
| Q3 24 | $-1.23 | $-0.53 | ||
| Q2 24 | $0.05 | — | ||
| Q1 24 | $0.01 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.6B | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $912.6M | $-10.5M |
| Total Assets | $11.9B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.7B | $18.9M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.0B | $5.4M | ||
| Q4 24 | $1.0B | $9.5M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.6B | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $912.6M | — | ||
| Q3 25 | $917.9M | $-10.5M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | $2.2M | ||
| Q4 24 | $1.1B | $15.4M | ||
| Q3 24 | $1.1B | $-3.9M | ||
| Q2 24 | $933.2M | — | ||
| Q1 24 | $928.7M | $17.7M |
| Q4 25 | $11.9B | — | ||
| Q3 25 | $11.9B | $235.2M | ||
| Q2 25 | $11.6B | — | ||
| Q1 25 | $12.6B | $237.7M | ||
| Q4 24 | $12.6B | $255.4M | ||
| Q3 24 | $13.4B | $246.8M | ||
| Q2 24 | $13.7B | — | ||
| Q1 24 | $13.6B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.9M | $1.8M |
| Free Cash FlowOCF − Capex | $-35.2M | $25.0K |
| FCF MarginFCF / Revenue | -72.8% | 0.1% |
| Capex IntensityCapex / Revenue | 6.9% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.9M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.9M | — | ||
| Q3 25 | $9.2M | $1.8M | ||
| Q2 25 | $-16.3M | — | ||
| Q1 25 | $-552.0K | $1.2M | ||
| Q4 24 | $-8.7M | $-6.1M | ||
| Q3 24 | $14.2M | $-613.0K | ||
| Q2 24 | $-9.1M | — | ||
| Q1 24 | $7.2M | $-1.4M |
| Q4 25 | $-35.2M | — | ||
| Q3 25 | $8.6M | $25.0K | ||
| Q2 25 | $-16.7M | — | ||
| Q1 25 | $-2.5M | $-4.3M | ||
| Q4 24 | $-11.4M | $-8.6M | ||
| Q3 24 | $13.4M | $-4.0M | ||
| Q2 24 | $-9.4M | — | ||
| Q1 24 | $5.9M | $-7.8M |
| Q4 25 | -72.8% | — | ||
| Q3 25 | 13.5% | 0.1% | ||
| Q2 25 | -32.4% | — | ||
| Q1 25 | -3.5% | -12.1% | ||
| Q4 24 | -123.5% | -26.3% | ||
| Q3 24 | 146.2% | -16.3% | ||
| Q2 24 | -16.3% | — | ||
| Q1 24 | 11.6% | -21.8% |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 1.0% | 5.6% | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 2.8% | 15.5% | ||
| Q4 24 | 29.4% | 7.5% | ||
| Q3 24 | 9.0% | 13.9% | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 2.5% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.96× | — | ||
| Q1 24 | 9.09× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FFWM
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
